Takeuchi Kazuhiko, Miyata Noriyuki, Renic Marija, Harder David R, Roman Richard J
Department of Physiology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA.
Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R84-9. doi: 10.1152/ajpregu.00445.2005. Epub 2005 Sep 15.
Recent studies have indicated that 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the fall in cerebral blood flow (CBF) after subarachnoid hemorrhage (SAH), but the factors that stimulate the production of 20-HETE are unknown. This study examines the role of vasoactive factors released by clotting blood vs. the scavenging of nitric oxide (NO) by hemoglobin (Hb) in the fall in CBF after SAH. Intracisternal (icv) injection of blood produced a greater and more prolonged (120 vs. 30 min) decrease in CBF than that produced by a 4% solution of Hb. Pretreating rats with N(omega)-nitro-l-arginine methyl ester (l-NAME; 10 mg/kg iv) to block the synthesis of NO had no effect on the fall in CBF produced by an icv injection of blood. l-NAME enhanced rather than attenuated the fall in CBF produced by an icv injection of Hb. Blockade of the synthesis of 20-HETE with TS-011 (0.1 mg/kg iv) prevented the sustained fall in CBF produced by an icv injection of blood and the transient vasoconstrictor response to Hb. Hb (0.1%) reduced the diameter of the basilar artery (BA) of rats in vitro by 10 +/- 2%. This response was reversed by TS-011 (100 nM). Pretreatment of vessels with l-NAME (300 muM) reduced the diameter of BA and blocked the subsequent vasoconstrictor response to the addition of Hb to the bath. TS-011 returned the diameter of vessels exposed to l-NAME and Hb to that of control. These results suggest that the fall in CBF after SAH is largely due to the release of vasoactive factors by clotting blood rather than the scavenging of NO by Hb and that 20-HETE contributes the vasoconstrictor response of cerebral vessels to both Hb and blood.
近期研究表明,20-羟基二十碳四烯酸(20-HETE)在蛛网膜下腔出血(SAH)后导致脑血流量(CBF)下降,但刺激20-HETE产生的因素尚不清楚。本研究探讨了凝血释放的血管活性因子与血红蛋白(Hb)清除一氧化氮(NO)在SAH后CBF下降中的作用。脑池内(icv)注射血液比注射4% Hb溶液导致CBF下降幅度更大、持续时间更长(分别为120分钟和30分钟)。用N(ω)-硝基-L-精氨酸甲酯(L-NAME;10 mg/kg静脉注射)预处理大鼠以阻断NO合成,对icv注射血液所致CBF下降无影响。L-NAME增强而非减弱了icv注射Hb所致的CBF下降。用TS-011(0.1 mg/kg静脉注射)阻断20-HETE合成可防止icv注射血液所致CBF持续下降以及对Hb的短暂血管收缩反应。0.1% Hb在体外使大鼠基底动脉(BA)直径缩小10±2%。TS-011(100 nM)可逆转该反应。用L-NAME(300 μM)预处理血管可使BA直径缩小,并阻断随后向浴槽中添加Hb时的血管收缩反应。TS-011使暴露于L-NAME和Hb的血管直径恢复至对照水平。这些结果表明,SAH后CBF下降主要是由于凝血释放血管活性因子,而非Hb清除NO,且20-HETE促成脑血管对Hb和血液的血管收缩反应。